Biostream Receives FDA Breakthrough Device Designation for a Urine Test to Aid the Diagnosis of Normal Pressure Hydrocephalus
Biostream's test measures proteins in a urine sample to help clinicians distinguish idiopathic normal pressure hydrocephalus (iNPH), a treatable cause of walking, memory and bladder problems, from Alzheimer's disease and other neurodegenerative disorders HAIFA, Israel, Nov. 18, 2026...
Short extract only — this publisher licenses its text. Read the full release at the source.
Free plan · Plus CA$29 or Pro CA$99/month


